Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety extension of controlled-release oxycodone in opioid-experienced children
2011-002235-26Phase 3Terminated
- Sponsor
- Purdue Pharma
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of oxycodone in pain, sponsored by Purdue Pharma. Primary endpoint: Safety analysis. Started Sep 2011; status: terminated.
02
Drugs
oxycodone
03
Conditions
pain
Beyond the preview
Go deeper on 2011-002235-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002235-26.